Hyglos GmbH specializes in providing advanced diagnostic solutions aimed at enhancing food safety and quality within the pharmaceutical and healthcare sectors. The company serves a diverse range of clients, including food manufacturers, pharmaceutical companies, and healthcare providers, who require reliable and efficient diagnostic tools to ensure the safety and quality of their products. Operating in the highly regulated markets of food safety and healthcare, Hyglos leverages its expertise in standard methods such as ISO, CEN, GMP, and FDA to offer cutting-edge solutions that meet stringent industry requirements.

Hyglos's business model revolves around the development and commercialization of diagnostic products that help clients make informed decisions, optimize their production processes, and ensure compliance with regulatory standards. The company generates revenue through the sale of its diagnostic kits and solutions, as well as through consulting services provided by its team of expert scientists. These scientists assist clients in identifying testing requirements, implementing rapid and alternative methods, and validating their processes to meet official standards.

By focusing on innovation and customer-centric solutions, Hyglos aims to provide its clients with the tools they need to improve their operational efficiency, reduce risks, and enhance their overall product quality. The company's commitment to advancing quality control testing for cell and gene therapy products further underscores its dedication to staying at the forefront of scientific advancements.

Keywords: Diagnostics, Food Safety, Quality Control, Pharma, Healthcare, ISO Standards, GMP, FDA Compliance, Rapid Testing, Cell Therapy.